Amfepramone hydrochloride

Product Describtion:The anti-inflammamtory properties and synthesis of carboxylic acid compounds containing benzo-1,4-dioxane (2,3-dihydro-1,4-benzodioxin) subunit was studied.Product Application：Benzo-1,4-dioxane (2,3-dihydro-1,4-benzodioxin) was

Product Describtion:The anti-inflammamtory properties and synthesis of carboxylic acid compounds containing benzo-1,4-dioxane (2,3-dihydro-1,4-benzodioxin) subunit was studied.Product Application：Benzo-1,4-dioxane (2,3-dihydro-1,4-benzodioxin) was

Biochem/physiol Actions Non-selective calcium channel blocker and class IV antiarrhythmic agent inhibits Na + -Ca 2+ exchange inhibits growth of brain tumor cells in vitro . Features and Benefits This compound was developed by Johnson &amp

General description Produced and qualified by HWI pharma services GmbH. Exact content by quantitative NMR can be found on the certificate.

Biochem/physiol Actions Irreversible &#956:, &#948: and &#954: opioid receptor antagonist. Features and Benefits This compound is featured on the Opioid Receptors page of the Handbook of Receptor Classification and Signal Transduction.

Biochem/physiol Actions Irreversible &#956:, &#948: and &#954: opioid receptor antagonist. Features and Benefits This compound is featured on the Opioid Receptors page of the Handbook of Receptor Classification and Signal Transduction.

BGJ398 (NVP-BGJ398) is a potent and selective FGFR inhibitor for FGFR1/2/3 with IC50 of 0.9 nM/1.4 nM/1 nM, &gt:40-fold selective for FGFR versus FGFR4 and VEGFR2, and little activity to Abl, Fyn, Kit, Lck, Lyn and Yes. Phase 2.A potent and

BMS 193885 is a potent, competitive NPY1-R antagonist (K|i|= 3.3 nM, IC|50|= 5.9 nM) that displays &gt: 47, &gt: 100, &gt: 160, &gt: 160 and &gt: 160-fold selectivity over σ1, α1, NPY2-R, NPY4-R and NPY5-R receptors respectively. Reduces food intake

BMS 193885 is a potent, competitive NPY1-R antagonist (K|i|= 3.3 nM, IC|50|= 5.9 nM) that displays &gt: 47, &gt: 100, &gt: 160, &gt: 160 and &gt: 160-fold selectivity over σ1, α1, NPY2-R, NPY4-R and NPY5-R receptors respectively. Reduces food intake

BMS 193885 is a potent, competitive NPY1-R antagonist (K|i|= 3.3 nM, IC|50|= 5.9 nM) that displays &gt: 47, &gt: 100, &gt: 160, &gt: 160 and &gt: 160-fold selectivity over σ1, α1, NPY2-R, NPY4-R and NPY5-R receptors respectively. Reduces food intake

BMS 193885 is a potent, competitive NPY1-R antagonist (K|i|= 3.3 nM, IC|50|= 5.9 nM) that displays &gt: 47, &gt: 100, &gt: 160, &gt: 160 and &gt: 160-fold selectivity over σ1, α1, NPY2-R, NPY4-R and NPY5-R receptors respectively. Reduces food intake

BMS 193885 is a potent, competitive NPY1-R antagonist (K|i|= 3.3 nM, IC|50|= 5.9 nM) that displays &gt: 47, &gt: 100, &gt: 160, &gt: 160 and &gt: 160-fold selectivity over σ1, α1, NPY2-R, NPY4-R and NPY5-R receptors respectively. Reduces food intake